Predict your next investment

HEALTHCARE | Pharmaceuticals / Drugs

See what CB Insights has to offer

Founded Year


Total Raised


About Jomaa Pharmaka

Developer of drugs to treat malaria and multiple sclerosis. The company has discovered the inherent factor missing in the human immune system which makes human beings susceptible to diseases such as malaria, multiple sclerosis and tuberculosis, and is developing drugs based on this factor, both to combat these ailments, and for use in applications in herbicides.

Jomaa Pharmaka Headquarter Location

Frankfurter Strasse 50



49 641797070

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.